While the link between anti-PD-1 monoclonal antibody therapy and ICI-related myocarditis is well established, the involvement of anti-CTLA-4 monoclonal antibody treatment in causing this condition remains uncertain. The gene discussed is CTLA4; the disease is myocarditis.